Invention Grant
US09115137B2 2,3,4,5-tetrahydro-1H-pyrido[4,3-B]indole compounds and methods of use thereof
有权
2,3,4,5-四氢-1H-吡啶并[4,3-B]吲哚化合物及其使用方法
![2,3,4,5-tetrahydro-1H-pyrido[4,3-B]indole compounds and methods of use thereof](/docs/US/2015-08-25/US09115137B2/abs.jpg.600x600.jpg)
- Patent Title: 2,3,4,5-tetrahydro-1H-pyrido[4,3-B]indole compounds and methods of use thereof
- Patent Title (中): 2,3,4,5-四氢-1H-吡啶并[4,3-B]吲哚化合物及其使用方法
-
Application No.: US12360061Application Date: 2009-01-26
-
Publication No.: US09115137B2Publication Date: 2015-08-25
- Inventor: David T. Hung , Andrew Asher Protter , Sarvajit Chakravarty , Rajendra Parasmal Jain
- Applicant: David T. Hung , Andrew Asher Protter , Sarvajit Chakravarty , Rajendra Parasmal Jain
- Applicant Address: US CA San Francisco
- Assignee: Medivation Technologies, Inc.
- Current Assignee: Medivation Technologies, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Morrison & Foerster LLP
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D487/14 ; C07D471/04 ; C07D471/14 ; C07D487/04
![2,3,4,5-tetrahydro-1H-pyrido[4,3-B]indole compounds and methods of use thereof](/abs-image/US/2015/08/25/US09115137B2/abs.jpg.150x150.jpg)
Abstract:
Provided are new tricyclic compounds that may be used to modulate a histamine receptor in an individual. Compounds are described, including new 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole compounds. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
Public/Granted literature
- US20100022580A1 NEW 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLE COMPOUNDS AND METHODS OF USE THEREOF Public/Granted day:2010-01-28
Information query
